- Chinese startups in hydrogen materials, AI marketing and immuno-diagnostics have completed fresh funding rounds
- The rounds will fund technology upgrades, production, AI models and overseas expansion
AstraBio raises $7.4 million in Series B for immuno-diagnostics
Suzhou-based single-molecule immuno-diagnostics company AstraBio (宇测生物) has completed a Series B financing round of more than 50 million yuan ($7.44 million).
The round was led by the Taizhou Advanced Manufacturing Industry Fund for Health and Life Sciences, with Univ and existing investor LHVentures participating.
AstraBio will use the proceeds to develop a full-cycle management platform for neurological diseases and expand its overseas commercialization efforts.
Founded in 2019, the company specializes in single-molecule immunoassay technology. Its core product is a fully automated single-molecule immunodiagnostic system designed for the precise detection of blood-based biomarkers associated with neurological diseases.
Its products have already entered clinical use. The company’s Alzheimer’s disease testing panel centered on p-tau217 and its SV2A assay, a domestically exclusive test for synaptic damage, have both received China’s Class II medical-device registration certificates.
AstraBio has also worked with several leading medical institutions and accumulated clinical data from tens of thousands of Chinese patients.
The company plans to combine its single-molecule immunodiagnostic technology with multi-omics approaches to build a full-cycle neurological disease management platform covering screening, diagnosis, monitoring, treatment guidance and rehabilitation and prognosis.
It initially plans to focus on neurodegenerative diseases before expanding into a broader range of brain-related conditions, including rare neurological diseases, cerebrovascular disorders and brain-health assessment.
KylinWay secures tens of millions of yuan for hydrogen materials
Hangzhou-based hydrogen-molecule materials company KylinWay (奇麟正维) has completed a Series A round worth tens of millions of yuan, led by Tiantu Capital.
The company will use the proceeds to upgrade its core technologies, build out a production base in Huzhou and expand its market presence.
Founded in 2022, KylinWay was jointly established by Hangzhou Industrial Investment Group and Jiangnan University’s School of Chemical and Material Engineering.
The company focuses on hydrogen-molecule transdermal anti-aging materials and has been recognized as a national high-tech enterprise.
KylinWay has developed two proprietary technologies: a solid-state, controllable hydrogen-storage dry-film technology and its HybridH₂Gen™ microcapsule technology, which generates hydrogen in situ in liquid formulations.
The technologies are designed to address several challenges that have limited the use of molecular hydrogen in cosmetics and personal-care products, including its low solubility and tendency to escape, poor storage stability and difficulty penetrating deeply enough to act on the skin.
The two technology platforms allow the company to cover a broader range of formulations and application scenarios, moving beyond single-use products toward a wider portfolio of hydrogen-infused products.
Third-party testing has shown that the company’s technology can increase transdermal absorption efficiency by 2.8 times, according to the company. KylinWay has already established partnerships with major domestic and international brands including Cosmax, Shiseido and Forest Cabin.
The company has also led 14 industry-academia-research institutions, including Jiangnan University, Zhejiang University, Proya and Shiseido, in developing China’s first group standard for hydrogen-rich dry-film cosmetic materials, titled Cosmetic Tools — Hydrogen-Rich Dry Film Cloth.
The standard is intended to fill a gap in industry standards for hydrogen-based cosmetics.
Noumena closes strategic funding from Jackery parent Hello Tech
Shanghai-based AI marketing-growth company Noumena (物自体科技) has completed a new strategic financing round worth tens of millions of yuan, led by portable-energy-storage company Hello Tech (华宝新能), the parent of the Jackery brand.
The funding will be used to scale the company’s BOOT methodology, develop vertical AI models for marketing and expand in domestic and overseas markets.
Founded in 2023, Noumena focuses on enterprise AI marketing transformation. Its proprietary BOOT methodology consists of four steps: breaking existing business structures, organizing AI-native teams, delivering measurable business results and transferring validated AI assets to clients.
The company has deployed its solutions across consumer electronics, beauty, medical aesthetics, restaurants, automotive and insurance, serving both listed companies with annual revenue in the tens of billions of yuan and fast-growing emerging brands. Its business now spans China and overseas markets.
Hello Tech’s Jackery brand sells products in more than 50 countries and regions worldwide.
The strategic investment followed business cooperation between the two companies, during which they saw the potential for AI-powered marketing to generate sustained improvements in enterprise growth.
Zhao Huan (赵欢), Noumena’s co-founder and chief scientist, said the company’s approach emphasizes the accumulation of business judgment through repeated validation against real commercial outcomes.
